Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

University of Toronto

$105,000.00

Integrative approaches for resolving the biological complexity of the cardiovascular complications associated with end-stage renal disease

FY 2017-18

Summary
An estimated three million Canadians have or are at risk of having chronic kidney disease. End-stage renal disease (ESRD), the last stage of chronic kidney disease, is a serious life-threatening condition in which the kidneys do not work well enough for survival without treatment. With the aging population, a growing number of people are developing ESRD. Cardiovascular problems are the leading cause of death in ESRD patients. Although there are some known risk-factors associated with cardiovascular mortality in ESRD, the biological pathways that are changed prior to cardiovascular events are severely understudied, making it difficult to identify which patients have the highest risk, and how best to treat them. To better identify, inform, and treat ESRD patients who have an increased risk of cardiovascular mortality we need to understand which biological pathways are changed. To address this gap in knowledge, I will utilize genetic sequencing and protein identification to discover biological pathways that are changed in patients with cardiovascular complications. Combining previously collected clinical data with these uncovered biological pathways will allow us to build an integrative risk-prediction model for the cardiovascular complications of ESRD. I expect this research will lead to the development of a tool physicians can use to better assess and treat patients with ESRD. In addition, knowing which molecular mechanisms cause cardiovascular complications will allow researchers to better understand how current therapies work and how more effective ones can be developed in the future. This may, as a whole, aid in decreasing the global health and economic burden of chronic kidney disease.
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
383330
Name
Gustafson Dakota D
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Integrative approaches for resolving the biological complexity of the cardiovascular complications associated with end-stage renal disease
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Biomarkers; Cardiology; Diabetes; Disease Mechanisms; End-Stage Renal Disease; Population Health
Abstract
An estimated three million Canadians have or are at risk of having chronic kidney disease. End-stage renal disease (ESRD), the last stage of chronic kidney disease, is a serious life-threatening condition in which the kidneys do not work well enough for survival without treatment. With the aging population, a growing number of people are developing ESRD. Cardiovascular problems are the leading cause of death in ESRD patients. Although there are some known risk-factors associated with cardiovascular mortality in ESRD, the biological pathways that are changed prior to cardiovascular events are severely understudied, making it difficult to identify which patients have the highest risk, and how best to treat them. To better identify, inform, and treat ESRD patients who have an increased risk of cardiovascular mortality we need to understand which biological pathways are changed. To address this gap in knowledge, I will utilize genetic sequencing and protein identification to discover biological pathways that are changed in patients with cardiovascular complications. Combining previously collected clinical data with these uncovered biological pathways will allow us to build an integrative risk-prediction model for the cardiovascular complications of ESRD. I expect this research will lead to the development of a tool physicians can use to better assess and treat patients with ESRD. In addition, knowing which molecular mechanisms cause cardiovascular complications will allow researchers to better understand how current therapies work and how more effective ones can be developed in the future. This may, as a whole, aid in decreasing the global health and economic burden of chronic kidney disease.
Competitiondate
201710
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Gustafson, Dakota D
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~